Gerold Schuler

Rapid control of therapy‐refractory pemphigus vulgaris by treatment with the tumour necrosis factor‐α inhibitor infliximab

G. Schuler, M. Hertl, A. Jacobi, 2005, The British journal of dermatology.

Treatment of inflammatory dermatoses by tumour necrosis factor antagonists

G. Schuler, M. Hertl, A. Jacobi, 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease).

G. Schuler, M. Hertl, M. Lüftl, 2001, Archives of dermatology.

Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients

A. Gesierich, S. Goerdt, C. Garbe, 2018, The British journal of dermatology.

Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan‐linked polyvinylalcohol adsorber

G. Schuler, M. Hertl, A. Mainka, 2003, The British journal of dermatology.